Fecal Pancreatic Elastase Testing Market Poised for Strong Growth: Projected to Reach US$ 31,842.3 Million by 2033, to Grow at an Impressive 7.6% CAGR | Future Market Insights Inc.
September 14, 2023 09:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The fecal pancreatic elastase testing market is expected to increase from US$ 15,306.7 million in 2023 to US$ 31,842.3 million by 2033. Acute...
Fecal Pancreatic Elastase Testing Market Is Set to Expand at A CAGR Of 7.7% To Reach US$ 30.2 Million By the Year 2032: FMI
April 20, 2022 11:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
Companies Profiled in Fecal Pancreatic Elastase Testing Market are Laboratory Corporation of America® Holdings, DiaSorin, ScheBo Biotech AG, Immundiagnostik AG, Invivo Healthcare, DRG Instruments...